Senior insider sale
SVP, Diagnostics, clonoSEQ at ADAPTIVE BIOTECHNOLOGIES CORP — senior position signals high conviction
$600.2K
41.34K shares
What this filing means
BOBULSKY SUSAN plans to sell 41.34K shares of ADAPTIVE BIOTECHNOLOGIES CORP valued at approximately $600.2K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 3/16/2026ACC: 0001820885-26-000006
Officer· SVP, Diagnostics, clonoSEQ
Since Aug 2020
41.34K
Shares to sell
$600.2K
Approx. market value
41.34K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Restricted Stock Units
N/A
3/10/2026
41.34KTotal acquired41.34K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
3/10/2026 | Restricted Stock Units N/A | 41.34K | — |
| Total | 41.34K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
41.34K
Market value
$600.2K
3/11/2026
Total
Units
41.34K
Value
$600.2K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
3/11/2026 | 41.34K | $600.2K | NASDAQ | Planned |
| Total | 41.34K | $600.2K | ||